ASH 2025 guideline for newly diagnosed AML in older adults makes 9 recommendations, including antileukaemic treatment over best supportive care, venetoclax-based regimens over monotherapies, and adding FLT3 inhibitors to induction and postremission therapy.
Guideline
Sekeres et al. American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults